Quality of Care and Economic Trade-offs

This topic examines the relationship between the quality of health care and its cost. Higher spending does not reliably buy better care, and a central question for health policy is how to obtain the best outcomes for a given level of resources — that is, how to maximise value rather than simply increase or cut spending.

Definition

The quality-cost relationship concerns how the structure, process, and outcomes of care vary with the resources spent on it, and how policy can improve value — defined as health outcomes achieved per unit of cost — rather than treating quality and cost as independent goals.

Scope

The entry covers how quality is conceptualised and measured, how it relates to cost, and the trade-offs that arise when policy seeks to improve outcomes within finite budgets. It introduces value as outcomes relative to cost and discusses overuse, underuse, and misuse as departures from high-value care. It is a reference topic on the economics of quality, not clinical guidance on any treatment.

Core questions

• Does spending more on health care produce better outcomes?
• How should the quality of care be defined and measured?
• What does it mean to maximise value rather than minimise cost?
• How do overuse, underuse, and misuse each affect the quality-cost balance?

Key concepts

• Value as outcomes relative to cost
• Donabedian's structure-process-outcome model
• Overuse, underuse, and misuse
• The Triple Aim
• Unwarranted variation in care
• Marginal returns to health spending

Mechanisms

Quality can be assessed along Donabedian's dimensions of structure, process, and outcome (Donabedian, 1988), and value frameworks relate those outcomes to the cost of producing them (Porter, 2010). Because the marginal return to additional spending often diminishes, more care is not always better care: overuse can add cost and risk without benefit, while underuse withholds beneficial care, and both lower value (Brownlee et al., 2017). System-improvement frameworks such as the Triple Aim seek to advance population health and patient experience while controlling per-capita cost, treating quality and cost as jointly optimisable rather than opposed (Berwick et al., 2008).

Clinical relevance

The way quality and cost are measured and rewarded shapes the incentives surrounding clinical practice and the resources available for it. Understanding these trade-offs helps health professionals interpret value-based policy and quality metrics; the entry describes system-level relationships and is not a basis for individual treatment decisions.

Evidence & guidelines

Evidence draws on health-services research and conceptual frameworks rather than a single trial hierarchy. Donabedian's model (1988) underpins quality measurement, Porter (2010) frames value, the Triple Aim (Berwick et al., 2008) frames system goals, and reviews of overuse (Brownlee et al., 2017) document where added spending fails to add value. There is no single clinical guideline; the field weighs how to align quality measurement with payment and resource use.

History

The systematic study of health care quality was shaped by Avedis Donabedian's structure-process-outcome framework in the latter twentieth century. As evidence accumulated that higher spending and more care did not consistently yield better outcomes, attention shifted toward value — outcomes relative to cost — and toward identifying overuse and unwarranted variation, themes consolidated in the value and Triple Aim frameworks of the 2000s (Porter, 2010; Berwick et al., 2008).

Debates

Does more health care spending improve outcomes?

Evidence of wide variation in spending without commensurate differences in outcomes, together with documented overuse, suggests the marginal return to additional care is often low; how far this generalises, and where added spending does help, remains debated.

Key figures

• Avedis Donabedian
• Michael Porter
• Donald Berwick
• Shannon Brownlee

Seminal works

• donabedian-1988
• porter-2010
• berwick-2008

Frequently asked questions

Does higher health spending always mean better care?

No. Evidence shows wide variation in spending without matching differences in outcomes, and some additional care provides little or no benefit, so the relationship between cost and quality is not simply that more is better.

What is meant by 'value' in this context?

Value refers to the health outcomes achieved relative to the cost of achieving them, so improving value means getting better outcomes for the same cost or the same outcomes at lower cost.